Fac Rev. 2021 Jun 29, .  et al. 0

Borloz E

Kaminska A, .  et al. 0

Laroche C

Sylviane, .  et al. 0

Yann; Villard

A., .  et al. 0

L.; Ragusa

, .  et al. 0

, .  et al. 0

Orphanet J Rare Dis. 2021 Jul 17, .  et al. 0

Jdila MB

Ghata A, .  et al. 0

Villard L

we uncovered an important reduction of brain ATP level, .  et al. 0

a hitherto undetected anomaly of energy metabolism that may reflect and contribute to cerebral injury and dysfunction.;17/02/2006;07/03/2016 15:19;07/03/2016 15:19;;776-783;;3;340;;Biochem. Biophys. Res. Commun.;;;;;;;;eng;;;;;PubMed;;PMID: 16380085

2.5% South Carolinian male college students, .  et al. 0

5% Italian male controls and 4.5% of the white South African controls. None of the black South African non-fragile X individuals with mental retardation

Marie-Solenne, .  et al. 0

Adeline; Espanet

, .  et al. 0

Genet Med. 2021 Nov, .  et al. 0

Iqbal M

bone malformations, .  et al. 0

and early death: a distinct MCA/MR syndrome M

K., .  et al. 0

A.; Carlier

, .  et al. 0

these results reveal that carbamazepine-epoxide accumulates in the brain when given over a long period of time. They also show that chronic treatment with carbamazepine strongly impacts cognitive abilities in a mouse model of Kcnq2-DEE, .  et al. 0

questioning current treatment strategies in human patients. PLAIN LANGUAGE SUMMA

and can thus be applied to a large number of patients at a low cost in any given laboratory., .  et al. 0

Center for History and New Media, .  et al. 0

Zotero Quick Start Guide

ATR-X/XNP/XH2 gene MIM #300032) Villard L, .  et al. 0

Fontes M. "Eur J Hum Genet. 2002 Apr;10(4):223-5. doi: 10.1038/sj.ejhg.5200800." Villard L Eur J Hum Genet 2002 29/05/2002 10.1038/sj.ejhg.5200800